Acquirement of DNA copy number variations in non‑small cell lung cancer metastasis to the brain

Li,Fang; Sun,Libo; Zhang,Sixun

doi:10.3892/or.2015.4188

Acquirement of DNA copy number variations in non‑small cell lung cancer metastasis to the brain

Authors:
- Fang Li
- Libo Sun
- Sixun Zhang
View Affiliations

Affiliations: Neurosurgery Department of China-Japan Friendship Hospital, Beijing 100029, P.R. China, Neurosurgery Department of China-Japan Union Hospital, Jilin University, Changchun, Jilin 130033, P.R. China
Published online on: August 10, 2015 https://doi.org/10.3892/or.2015.4188
Pages: 1701-1707
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Brain metastasis is a major complication of non‑small cell lung cancer (NSCLC) and leads to most of the mortality of this disease. However, the biological mechanisms and molecular features in brain metastasis of NSCLC are poorly understood. In the present study, we compared whole‑genome copy number variations (CNVs) between a primary lung adenocarcinoma and secondary metastatic brain lesion from the same patient using array comparative genomic hybridization (aCGH). The number of CNV regions was markedly higher in the secondary metastatic tumor than the primary tumor in the lung. In detail, the common CNVs in both tumors included gains of 7p22, 7p12-p11, 7q11, 7q22, 21q22, and 19q13; gains of 1p33-p34, 1q22, 5p13 and 14q11 whereas losses of 3p, 4q31, 5q, 11p15, Xp21-p22 and Xq21 were identified only in the secondary lesion. Gene Ontology enrichment analysis revealed that the genes with amplified copy numbers in both tumors were related to such processes as DNA replication and mismatch repair. Genes only amplified in the metastatic tumor were enriched in processes that include leukocyte migration and organ development, and genes with a lower copy number in the secondary tumor included the processes of proteolysis regulation, negative regulation of cell proliferation and cell adhesion. These findings provided new insight into the genomic mechanism of the spread of lung adenocarcinoma to the brain, and the candidate genes identified serve as novel indicators or putative targets in NSCLC brain metastasis.

View Figures

View References

1	Spira A and Ettinger DS: Multidisciplinary management of lung cancer. N Engl J Med. 350:379–392. 2004. View Article : Google Scholar : PubMed/NCBI
2	Quint LE, Tummala S, Brisson LJ, Francis IR, Krupnick AS, Kazerooni EA, Iannettoni MD, Whyte RI and Orringer MB: Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg. 62:246–250. 1996. View Article : Google Scholar : PubMed/NCBI
3	Han L, Liang XH, Chen LX, Bao SM and Yan ZQ: SIRT1 is highly expressed in brain metastasis tissues of non-small cell lung cancer (NSCLC) and in positive regulation of NSCLC cell migration. Int J Clin Exp Pathol. 6:2357–2365. 2013.PubMed/NCBI
4	Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P and Sawaya RE: Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 22:2865–2872. 2004. View Article : Google Scholar : PubMed/NCBI
5	Stuschke M, Eberhardt W, Pöttgen C, Stamatis G, Wilke H, Stüben G, Stöblen F, Wilhelm HH, Menker H, Teschler H, et al: Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: Long-term follow-up and investigations of late neuropsychologic effects. J Clin Oncol. 17:2700–2709. 1999.PubMed/NCBI
6	Wang SY, Ye X, Ou W, Lin YB, Zhang BB and Yang H: Risk of cerebral metastases for postoperative locally advanced non-small-cell lung cancer. Lung Cancer. 64:238–243. 2009. View Article : Google Scholar
7	Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrick A, Menker H, Krause B, Müeller MR, Stahl M, Flasshove M, et al: Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: Mature results of a phase II trial. J Clin Oncol. 16:622–634. 1998.PubMed/NCBI
8	Knisely JP, Berkey B, Chakravarti A, Yung AW, Curran WJ Jr, Robins HI, Movsas B, Brachman DG, Henderson RH and Mehta MP: A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118). Int J Radiat Oncol Biol Phys. 71:79–86. 2008. View Article : Google Scholar : PubMed/NCBI
9	Fidler IJ: The role of the organ microenvironment in brain metastasis. Semin Cancer Biol. 21:107–112. 2011. View Article : Google Scholar
10	Zhao C, Xu Y, Zhang Y, Tan W, Xue J, Yang Z, Zhang Y, Lu Y and Hu X: Downregulation of miR-145 contributes to lung adenocarcinoma cell growth to form brain metastases. Oncol Rep. 30:2027–2034. 2013.PubMed/NCBI
11	Cavallaro S: CXCR4/CXCL12 in non-small-cell lung cancer metastasis to the brain. Int J Mol Sci. 14:1713–1727. 2013. View Article : Google Scholar : PubMed/NCBI
12	Vogetseder A, Thies S, Ingold B, Roth P, Weller M, Schraml P, Goodman SL and Moch H: αv-Integrin isoform expression in primary human tumors and brain metastases. Int J Cancer. 133:2362–2371. 2013. View Article : Google Scholar : PubMed/NCBI
13	Pang X, Min J, Liu L, Liu Y, Ma N and Zhang H: S100B protein as a possible participant in the brain metastasis of NSCLC. Med Oncol. 29:2626–2632. 2012. View Article : Google Scholar : PubMed/NCBI
14	Rojiani MV, Alidina J, Esposito N and Rojiani AM: Expression of MMP-2 correlates with increased angiogenesis in CNS metastasis of lung carcinoma. Int J Clin Exp Pathol. 3:775–781. 2010.PubMed/NCBI
15	Preusser M, Berghoff AS, Berger W, Ilhan-Mutlu A, Dinhof C, Widhalm G, Dieckmann K, Wöhrer A, Hackl M, von Deimling A, et al: High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer. Lung Cancer. 83:83–89. 2014. View Article : Google Scholar
16	Lee HW, Seol HJ, Choi YL, Ju HJ, Joo KM, Ko YH, Lee JI and Nam DH: Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer. Int J Oncol. 41:2013–2020. 2012.PubMed/NCBI
17	Olshen AB, Venkatraman ES, Lucito R and Wigler M: Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics. 5:557–572. 2004. View Article : Google Scholar : PubMed/NCBI
18	Venkatraman ES and Olshen AB: A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics. 23:657–663. 2007. View Article : Google Scholar : PubMed/NCBI
19	Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Jones SJ and Marra MA: Circos: An information aesthetic for comparative genomics. Genome Res. 19:1639–1645. 2009. View Article : Google Scholar : PubMed/NCBI
20	Benjamini Y and Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series. 57:289–300. 1995.
21	Casorzo L, Corigliano M, Ferrero P, Venesio T and Risio M: Evaluation of 7q31 region improves the accuracy of EGFR FISH assay in non small cell lung cancer. Diagn Pathol. 4:362009. View Article : Google Scholar : PubMed/NCBI
22	Wrage M, Ruosaari S, Eijk PP, Kaifi JT, Hollmén J, Yekebas EF, Izbicki JR, Brakenhoff RH, Streichert T, Riethdorf S, et al: Genomic profiles associated with early micrometastasis in lung cancer: Relevance of 4q deletion. Clin Cancer Res. 15:1566–1574. 2009. View Article : Google Scholar : PubMed/NCBI
23	Lee HJ, Song IC, Yun HJ, Jo DY and Kim S: CXC chemokines and chemokine receptors in gastric cancer: From basic findings towards therapeutic targeting. World J Gastroenterol. 20:1681–1693. 2014. View Article : Google Scholar : PubMed/NCBI
24	Sarvaiya PJ, Guo D, Ulasov I, Gabikian P and Lesniak MS: Chemokines in tumor progression and metastasis. Oncotarget. 4:2171–2185. 2013.PubMed/NCBI
25	He G, Zhang B, Zhang B, Qiao L, Tian Z, Zhai G, Xin X, Yang C, Liu P, Zhang Y, et al: Th17 cells and IL-17 are increased in patients with brain metastases from the primary lung cancer. Zhongguo Fei Ai Za Zhi. 16:476–481. 2013.In Chinese. PubMed/NCBI
26	Gilkes DM, Semenza GL and Wirtz D: Hypoxia and the extracellular matrix: Drivers of tumour metastasis. Nat Rev Cancer. 14:430–439. 2014. View Article : Google Scholar : PubMed/NCBI
27	Schroder WA, Major LD, Le TT, Gardner J, Sweet MJ, Janciauskiene S and Suhrbier A: Tumor cell-expressed SerpinB2 is present on microparticles and inhibits metastasis. Cancer Med. 3:500–513. 2014. View Article : Google Scholar : PubMed/NCBI
28	Grinberg-Rashi H, Ofek E, Perelman M, Skarda J, Yaron P, Hajdúch M, Jacob-Hirsch J, Amariglio N, Krupsky M, Simansky DA, et al: The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain. Clin Cancer Res. 15:1755–1761. 2009. View Article : Google Scholar : PubMed/NCBI
29	Hong LZ, Wei XW, Chen JF and Shi Y: Overexpression of periostin predicts poor prognosis in non-small cell lung cancer. Oncol Lett. 6:1595–1603. 2013.PubMed/NCBI
30	Su LK, Vogelstein B and Kinzler KW: Association of the APC tumor suppressor protein with catenins. Science. 262:1734–1737. 1993. View Article : Google Scholar : PubMed/NCBI
31	Chu EC and Tarnawski AS: PTEN regulatory functions in tumor suppression and cell biology. Med Sci Monit. 10:RA235–RA241. 2004.PubMed/NCBI
32	Pećina-Šlaus N, Nikuševa Martić T, Zeljko M and Bulat S: Brain metastases exhibit gross deletions of the APC gene. Brain Tumor Pathol. 28:223–228. 2011. View Article : Google Scholar
33	Fidler MJ, Morrison LE, Basu S, Buckingham L, Walters K, Batus M, Jacobson KK, Jewell SS, Coon J IV and Bonomi PD: PTEN and PIK3CA gene copy numbers and poor outcomes in non-small cell lung cancer patients with gefitinib therapy. Br J Cancer. 105:1920–1926. 2011. View Article : Google Scholar : PubMed/NCBI